HIMS
Stock and Options Trade Setup — Hims & Hers Health, Inc.
NYSE · Telehealth & Direct-to-Consumer Health · Moderate-liquidity options · Mid cap · ~$5.2B
Hims & Hers is one of the most compelling consumer health growth stories in the mid-cap universe — a platform that is structurally capturing patients who have been underserved by traditional healthcare: young adults who want convenient, affordable, and stigma-free access to prescriptions for ED, hair loss, anxiety, and now weight management. The GLP-1 opportunity is the biggest near-term catalyst: HIMS launched compounded semaglutide and tirzepatide at a fraction of brand-name prices, attracting hundreds of thousands of new subscribers seeking affordable weight loss medication. While regulatory risk around compounded GLP-1s creates binary headline risk, the underlying consumer demand is not going away. Subscriber growth, average revenue per user, and gross margin expansion are all trending in the right direction. The platform has the potential to become the CVS of digital-first consumer healthcare.
Last 3 HIMS Setups — Logged & Resolved
The most recent setups the scanner delivered for HIMS — logged at delivery, resolved when stop or target was hit.
Score History & Signal Changelog
● Live dataThis page is updated every 72 hours with the latest Scan results. Each data point below represents one complete algorithmic snapshot in time.
Signal Breakdown
Today's Trade Card
Options Profile
Risks & Fundamentals
Every setup carries risk. Here's what could move HIMS against you, plus the key stats that frame any position.
- 1.FDA compounded GLP-1 regulation is the primary binary risk — reclassification of semaglutide shortage status could force HIMS to stop selling compounded versions
- 2.High customer acquisition cost in a competitive DTC health market; churn rates for subscription health products can be elevated
- 3.Profitability is still nascent; the company burns cash at the current growth rate and relies on continued revenue growth to reach sustainable FCF
HIMS Options Setup — Frequently Asked Questions
Is HIMS a good options trade today?+
Hims & Hers Health, Inc. (HIMS) currently has an Amora Edge Score of 65/100, ranking it top 40%. This composite score is built from four sub-signals — EMA cross, RSI zone, relative strength vs SPY, and volume surge — each scored 0–25. The current read is a watchlist setup, so the algorithm is positioned bullish (calls / call debit spreads). A score above 65 typically warrants a trade card with stop and target; below that, the setup is on the watchlist but not actionable.
What is HIMS's win rate on Stoptions.ai setups?+
HIMS's historical win rate on closed Stoptions setups is 86%. Win rate is calculated as the percentage of past HIMS trade cards that hit their target price before stopping out. Win rate is most meaningful once a ticker has 10+ closed trades — individual ticker rates can be noisy at smaller samples. Our portfolio-wide win rate across all closed trades is the more stable benchmark.
What strike and expiry does Stoptions.ai suggest for HIMS?+
The strike and expiry are shown on the trade card at the top of this page when the setup is active. Stoptions.ai algorithmically selects strikes targeting delta 0.35–0.45 and expirations 30–45 days out, adjusted for current implied volatility rank (IVR). When IVR is high, the system favors call debit spreads to limit vega risk; when IVR is low, single-leg long calls are preferred. The card includes the contract symbol, mid-price entry, stop, and target.
How often is the HIMS setup updated?+
Every 72 hours we refresh HIMS's Amora Edge Score and trade card. The underlying scan runs daily at 9:00 AM ET (pre-market) and 9:30 AM ET (post-open), so any new signal change is reflected within one trading session. If HIMS drops below the entry threshold or the regime shifts (e.g., SPY enters a confirmed bear), the trade card is replaced with a "no setup" notice automatically.
What does the Amora Edge Score measure for HIMS?+
The Amora Edge Score is a 0–100 composite of four technical sub-signals applied to HIMS: (1) EMA cross — is the 20-day above the 50-day with both trending up? (2) RSI zone — is momentum in the 50–70 sweet spot, or extended/weak? (3) Relative strength vs SPY — is HIMS outperforming the market over 20 sessions? (4) Volume surge — is participation above the 20-day average? Each sub-signal contributes 0–25 points. HIMS currently scores 65.
How does HIMS compare to other Telehealth & Direct-to-Consumer Health setups?+
HIMS's sector rank and percentile against other Telehealth & Direct-to-Consumer Health tickers we track is shown on the /tickers index — sortable by Amora Edge Score, win rate, or sector. For direct comparison, see the "Related Telehealth & Direct-to-Consumer Health Options Setups" panel above. When multiple tickers in the same sector are scoring 80+, the algorithm flags the cluster as a sector rotation signal and may upweight position sizing.
Educational content only — not personalized investment advice. Options carry substantial risk.
Get a Friday Recap Including Setups Like HIMS.
Every Friday at 4:30 PM ET — Trade of the Week, Signal Movement, Sector Spotlight, Technical Analysis, and more. A 4-minute read. Free.
No spam. One email Friday afternoon. Unsubscribe in one click.